Treatment of hairy cell leukemia with cladribine (2- chlorodeoxyadenosine)

Wiener Klinische Wochenschrift

Volumn 111, Issue 24, 1999, Pages 1027-1030

  Füreder, Wolfgang ^a   Weltermann, Ansgar ^b   Chott, Andreas ^b   Gisslinger, Heinz ^b   Valent, Peter ^b   Jäger, Ulrich ^b   Geissler, Klaus ^b   Lechner, Klaus ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

2 chlorodeoxyadenosine; Hairy cell leukemia; Interferon; Treatment

Indexed keywords

ALPHA INTERFERON; CLADRIBINE; PENTOSTATIN;

ADULT; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG POTENCY; FEMALE; FEVER; HAIRY CELL LEUKEMIA; HUMAN; LEUKEMIA REMISSION; MALE; NEUTROPENIA; TREATMENT OUTCOME;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CLADRIBINE; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; PENTOSTATIN; RECURRENCE; REMISSION INDUCTION; SPLENECTOMY; TIME FACTORS;

EID: 0342545420     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bouroncle BA, Wiseman BK, Doan CA (1958) Leukemic reticuloendotheliocytosis. Blood 13: 609-630
2. Catovsky D (1977) Hairy cell leukemia and prolymphocytic leukemia. Clin Haematol 6: 245-268
3. Colomb HM, Catovsky D, Golde DW (1978) Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med 89: 677-683
4. Korsmeyer SJ, Greene WC, Cossman, Hsu SM, Jensen JP, Neckers LM, et al (1983) Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci USA 80: 4522-4526
5. Jansen J, den Ottolander GJ, Schuit HR, Waayer JL, Hijmans W (1984) Hairy cell leukemia: its place in the chronic B-cell leukemias. Semin Oncol 11: 386-393
6. Anderson KC, Boyd AW, Fisher DC, Leslie D, Schlossman SF, Nadler LM (1985) Hairy cell leukemia: a tumor of pre-plasma cells. Blood 65: 620-629
7. Golomb HM, Catovsky D, Golde DW (1983) Hairy cell leukemia: a five year update on seventy five patients. Ann Intern Med 99: 485-486
8. Golde DW (1982) Therapy of hairy cell leukemia. N Engl J Med 307: 495-496
9. Mintz U, Golomb HM (1979) Splenectomy as initial therapy in twenty six patients with reticuloentheliocytosis (hairy cell leukemia). Cancer Res 39: 2366-2370
10. Golomb HM, Vardiman JW (1983) Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood 61: 349-352
11. Jansen J, Hermans J (1981) Splenectomy in hairy cell leukemia: a retrospective multicenter analysis. Cancer 47: 2066-2076
12. Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU (1984) Alpha interferon for induction of remission in hairy cell leukemia. N Engl J Med 310: 15-18
13. Quesada JR, Hersh EM, Manning JT, Reuben J, Keating M. Schnipper E, et al (1988) Treatment of hairy cell leukemia with recombinant alpha-interferon. Blood 68: 493-497
14. Schwarzinger I, Bettelheim P, Choit A, Herold C, Hinterberger W, Koller U, et al (1988) Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients. Wien Klin Wochenschr 100: 47-51
15. Piro LD, Carrera CJ, Carson DA, Beutler E (1990) Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 322: 1117-1121
16. Tallman MS, Hakimian D, Variakojis D, Koslow D, Sisney GA, Rademaker AW, et al (1992) A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 80: 2203-2209
17. Estey EH, Kurzrock R, Kantarjian HM, O'Brian SM, McCredie KB, Beran M, et al (1992) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 79: 882-887
18. Seto S, Carrera CJ, Kubota M, Wasson DB, Carson DA (1985) Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J Clin Invest 75: 377-383
19. Hirota Y, Yoshioka A, Tanaka S, Watanable K, Otani T, Minowada J, et al (1989) Imbalance of deoxyribonucleoside triphosphates, DNA double strand breakes, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells. Cancer Res 49: 915-919
20. Carson DA, Wasson DB, Taetle R, Yu A (1983) Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood 62: 737-743
21. Cheson BD, Sorensen JM, Vena DA, Montello MJ, Barrett JA, Damasio E, et al (1998) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the group C protocol mechanism of the National Cancer Institute. A report of 979 patients. J Clin Oncol 16: 3007-3015
22. Saven A, Burian C, Koziol JA, Piro LD (1998) Long-term follow up of patients with hairy cell leukemia after cladribine treatment. Blood 92: 1918-1926
23. Hoffman MA, Janson D, Rose E, Rai KR (1998) Treatment of hairy cell leukemia with cladribine: response, toxicity, and long term follow up. J Clin Oncol 15: 1138-1142
24. Zaja F, Fanin R, Silvestri F, Russo D, Infanti L, Baccarani M (1997) Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine. Haematologica 82: 468-470
25. Robak T, Blasinska-Morawiec M, Blonski J, Hellmann A, Halaburda K, Konopka L, et al (1999) 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. Eur J Haematol 62: 49-56
26. Kurzrock R, Strom SS, Estey E, O'Brian S, Keating MJ, Jiang H, et al (1997) Second cancer risk in hairy cell leukemia: analysis of 350 patients. J Clin Oncol 15: 1803-1810
27. Au WY, Klasa RJ, Gallagher R, Le N, Gascoyne RD, Connors JM (1998) Second malignancies in patients with hairy cell leukemia in British Colombia: a 20-year experience. Blood 92: 1160-1164
28. Lorber C, Willfort A, Öhler L, Jäger U, Schwarzinger I, Lechner K, et al (1993) Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon alpha therapy of neutropenic patients with hairy cell leukemia. Ann Hematol 67: 13-16
29. Legrand O, Vekhoff A, Marie JP, Zittoun R, Delmer A (1997) Treatment of hairy cell leukemia (HCL) with 2-chlorodeoxyadenosine (2-CdA): identification of parameters predictive of adverse effects. Br J Haematol 99: 165 167